Publications by authors named "Lawrence Fong"

115Publications

Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T.

Cancer Immunol Res 2020 Dec 23;8(12):1496-1507. Epub 2020 Sep 23.

Department of Medicine, University of California San Francisco, San Francisco, California.

View Article and Find Full Text PDF
December 2020

Outlook of tourism recovery amid an epidemic: Importance of outbreak control by the government.

Ann Tour Res 2020 May 25:102951. Epub 2020 May 25.

School of Tourism Management, South China Normal University, Guangzhou, China.

View Article and Find Full Text PDF
May 2020

An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET Radiotracers.

Mol Imaging Biol 2020 12 19;22(6):1553-1561. Epub 2020 Aug 19.

Department of Radiology and Biomedical Imaging, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143, USA.

View Article and Find Full Text PDF
December 2020

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.

Mol Ther 2020 11 21;28(11):2367-2378. Epub 2020 Jul 21.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article and Find Full Text PDF
November 2020

Intratumoral CD4 T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.

Cell 2020 06 3;181(7):1612-1625.e13. Epub 2020 Jun 3.

Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address:

View Article and Find Full Text PDF
June 2020

Immune Checkpoint Blockade for Prostate Cancer: Niche Role or Next Breakthrough?

Am Soc Clin Oncol Educ Book 2020 Mar;40:1-18

Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article and Find Full Text PDF
March 2020

Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.

J Natl Cancer Inst 2020 06;112(6):562-573

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article and Find Full Text PDF
June 2020

Immune Checkpoint Inhibition in Prostate Cancer.

Trends Cancer 2020 03 6;6(3):174-177. Epub 2020 Feb 6.

Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA. Electronic address:

View Article and Find Full Text PDF
March 2020

Tissue Determinants of Human NK Cell Development, Function, and Residence.

Cell 2020 02 13;180(4):749-763.e13. Epub 2020 Feb 13.

Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032, USA; Department of Surgery, Columbia University Medical Center, New York, NY 10032, USA; Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA. Electronic address:

View Article and Find Full Text PDF
February 2020

TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer.

Front Immunol 2019 9;10:2985. Epub 2020 Jan 9.

Division of Hematology and Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.

View Article and Find Full Text PDF
November 2020